Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BCG, NeisVac-C, Pediacel, Infanrix, Prevenar-13, Menitorix, Priorix, Rotarix
- Development stage
- Unknown
- Lead developer
- GSK
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Administration
- Intramuscular, Intradermal, Oral, Subcutaneous
01
Overview
This entry refers to a comprehensive collection of pediatric vaccine products typically utilized in childhood immunization schedules to prevent a wide array of infectious diseases. The list includes **BCG** (Bacillus Calmette-Guérin) for tuberculosis prevention; **NeisVac-C** for protection against *Neisseria meningitidis* serogroup C; **Pediacel**, a pentavalent vaccine covering diphtheria, tetanus, pertussis, poliomyelitis, and *Haemophilus influenzae* type b (Hib); **Infanrix**, a trivalent DTaP vaccine; **Prevenar-13** (PCV13), a 13-valent pneumococcal conjugate vaccine; **Menitorix**, a combined Hib and Meningitis C conjugate vaccine; **Priorix**, a live-attenuated measles, mumps, and rubella (MMR) vaccine; and **Rotarix**, an oral live-attenuated rotavirus vaccine. These products utilize various platforms, including live-attenuated bacterial and viral strains, polysaccharide-protein conjugates, and inactivated toxoids or subunits, to stimulate active immunity and immunological memory against their respective target pathogens.
- Brand names
- BCGNeisVac-CPediacelInfanrixPrevenar-13Prevenar13Prevenar 13MenitorixPriorixRotarix
- Other names
- BCG vaccinePCV13PCV-13PCV 13MMR vaccineRotavirus vaccineDTaP-IPV-Hib vaccineHib-MenC vaccineMenC vaccine
02
Targets
Diphtheria toxinPRNP (Cellular Prion Protein)Neisseria meningitidis group C capsular polysaccharideCPS (Streptococcus pneumoniae capsular polysaccharide)
Beyond the preview
Go deeper on BCG, NeisVac-C, Pediacel, Infanrix, Prevenar-13, Menitorix, Priorix, Rotarix.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BCG, NeisVac-C, Pediacel, Infanrix, Prevenar-13, Menitorix, Priorix, Rotarix.